Senti Biosciences Holdings SNTI Insider Ownership

NASDAQ SNTI
$0.16 +0.02 (+11.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Insider Holdings by Owner

17.79Mn Shares
Partners Spv 24 Celadon9.78Mn55.0%
Enterprise Associates 15, L.P. New3.78Mn21.2%
Healthcare Llc Bayer2.81Mn15.8%
Omid Farokhzad866.29K4.9%
Timothy K Lu482.27K2.7%
Other insiders (3)80.32K0.5%

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
54.94%
▼-2.70% pp QoQ
Shares Held by Insiders
17.11Mn
filed for Sep 2026
▼-4.69% QoQ
Shares Outstanding
31.14Mn
31,144,754 shares
Direct Holdings
17.08Mn
Indirect: 33.00K
Net Open-Market Trades
0
no open-market trades in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Open-Market Insider Trades

Bought Sold
Latest quarter —
Net over range —
Net-buying quarters —

Insider Ownership Summary

Over the past year, SNTI insiders did not buy or sell the stock on the open market.

Form 4 Holdings

Insiders Holding SNTI

Insiders 8
Shares held 17.79Mn
Of outstanding 57.12%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Partners Spv 24 Celadon TenPercentOwner 9,777,000 0 9,777,000 55.0% 14 Mar, 2025
2 Enterprise Associates 15, L.P. New TenPercentOwner 3,775,615 0 3,775,615 21.2% 12 Mar, 2025
3 Healthcare Llc Bayer TenPercentOwner 2,809,848 0 2,809,848 15.8% 12 Mar, 2025
4 Omid Farokhzad Director 0 866,290 866,290 4.9% 10 Jun, 2022
5 Timothy K Lu Ceo 482,271 0 482,271 2.7% 23 Oct, 2026
6 Kanya Rajangam Pres. Chief Med. Dev. Off. 54,890 0 54,890 0.3% 22 Oct, 2026
7 Deborah Knobelman Chief Financial Officer 13,100 0 13,100 0.1% 02 Feb, 2024
8 David R Epstein Director 12,325 0 12,325 0.1% 10 Jun, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

79 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
21 Oct, 2026 Timothy K Lu Ceo Disposed F 157,312 $0.00 $0 482,271 Direct
21 Oct, 2026 Kanya Rajangam Pres. Chief Med. Dev. Off. Disposed F 19,953 $0.00 $0 54,890 Direct
09 Mar, 2026 Kanya Rajangam Pres. Chief Med. Dev. Off. Disposed F 10,757 $0.00 $0 74,843 Direct
09 Mar, 2026 Timothy K Lu Ceo Disposed F 80,666 $0.00 $0 639,583 Direct
02 Feb, 2026 Timothy K Lu Ceo Disposed F 4,191 $0.00 $0 720,249 Direct
02 Feb, 2026 Kanya Rajangam Pres. Chief Med. Dev. Off. Disposed F 1,384 $0.00 $0 85,600 Direct
18 Jul, 2025 Bryan Daniel Baum Director Acquired A 43,900 $0.00 $0 43,900 Direct
25 Jun, 2025 James J. Collins Director Acquired A 21,950 $0.00 $0 21,950 Direct
25 Jun, 2025 Edward T Mathers Director Acquired A 21,950 $0.00 $0 21,950 Direct
25 Jun, 2025 Feng Hsiung Director Acquired A 21,950 $0.00 $0 21,950 Direct
25 Jun, 2025 Fran Schulz Director Acquired A 21,950 $0.00 $0 21,950 Direct
25 Jun, 2025 Brenda Cooperstone Director Acquired A 21,950 $0.00 $0 21,950 Direct
25 Jun, 2025 Donald F Tang Director Acquired A 21,950 $0.00 $0 21,950 Direct
10 Mar, 2025 Partners Spv 24 Celadon TenPercentOwner Acquired C 9,777,000 — — 9,777,000 Direct
10 Mar, 2025 Partners Spv 24 Celadon TenPercentOwner Disposed C 9,777 — — 0 Direct
10 Mar, 2025 Healthcare Llc Bayer TenPercentOwner Acquired C 2,222,000 — — 2,809,848 Direct
10 Mar, 2025 Enterprise Associates 15, L.P. New TenPercentOwner Acquired C 3,333,000 — — 3,775,615 Direct
10 Mar, 2025 Enterprise Associates 15, L.P. New TenPercentOwner Disposed C 3,333 — — 0 Direct
10 Mar, 2025 Healthcare Llc Bayer TenPercentOwner Disposed C 2,222 — — 0 Direct
07 Mar, 2025 John Harry Iii Cross Chief Financial Officer Acquired A 174,200 $0.00 $0 174,200 Direct